Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $373.0500 (3.34%) ($359.9350 - $373.3600) on Mon. Feb. 27, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.97% (three month average) | RSI | 58 | Latest Price | $373.0500(3.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(44%) IVW(42%) QQQ(42%) | Factors Impacting REGN price | REGN will decline at least -0.985% in a week (0% probabilities). VIXM(-8%) UUP(-8%) TLT(-6%) TIP(-2%) IPO(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.985% (StdDev 1.97%) | Hourly BBV | 0 () | Intraday Trend | 3.3% | | | |
|
5 Day Moving Average | $367.37(1.55%) | 10 Day Moving Average | $371.44(0.43%) | 20 Day Moving Average | $365.17(2.16%) | To recent high | -4.4% | To recent low | 9.5% | Market Cap | $39.554b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |